AN2718
CAS No. 174672-06-1
AN2718 ( AN2718 | AN-2718 | AN 2718 )
产品货号. M17372 CAS No. 174672-06-1
AN2718 是一种苯并氧杂硼化合物,在体外表现出广泛的抗真菌功效。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥376 | 有现货 |
|
| 10MG | ¥566 | 有现货 |
|
| 25MG | ¥1107 | 有现货 |
|
| 50MG | ¥1786 | 有现货 |
|
| 100MG | ¥2925 | 有现货 |
|
| 200MG | ¥4185 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥332 | 有现货 |
|
生物学信息
-
产品名称AN2718
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述AN2718 是一种苯并氧杂硼化合物,在体外表现出广泛的抗真菌功效。
-
产品描述AN2718 is a novel boron-containing small molecule that inhibits an essential protein synthesis enzyme, leucyl-transfer RNA synthetase, or LeuRS. This enzyme plays an essential role in fungal protein synthesis by attaching the leucine amino acid to transfer RNA, or tRNA. AN2718, an investigational topical anti-fungal product candidate for the potential treatment of skin and nail infections. At various concentrations, AN2718 gel showed low irritation potential, leading investigators to conclude that application site reactions in future efficacy trials would be unlikely.(In Vitro):AN2718 inhibits cytoplasmic LeuRS from molds, A. fumigatus, and from yeasts, C. albicans, with an IC50 of 2 μM and 4.2 μM, respectively. AN2718 has good MIC90 activity against the dermatophytes, T. rubrum and T.mentagrophytes.
-
体外实验AN2718 inhibits cytoplasmic LeuRS from molds, A. fumigatus, and from yeasts, C. albicans, with an IC50 of 2 μM and 4.2 μM, respectively. AN2718 has good MIC90 activity against the dermatophytes, T. rubrum and T.mentagrophytes.
-
体内实验——
-
同义词AN2718 | AN-2718 | AN 2718
-
通路Metabolic Enzyme/Protease
-
靶点DPP
-
受体leucyl-tRN/A synthetase
-
研究领域——
-
适应症——
化学信息
-
CAS Number174672-06-1
-
分子量168.4
-
分子式C7H6BClO2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : ≥ 50 mg/mL (296.93 mM)
-
SMILESc12c(ccc(c1)Cl)B(OC2)O
-
化学全称5-chlorobenzo[c][1,2]oxaborol-1(3H)-ol
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Aditya K Gupta., et al. InvestigatioN/Al drugs for onychomycosis. Expert Opin Investig Drugs. 2014 Jan;23(1):97-106.
产品手册
关联产品
-
Sitagliptin
西他列汀是一种新型口服降血糖(抗糖尿病药)的新型二肽基肽酶4(DPP-4)抑制剂类化合物。
-
Saxagliptin
一种高效、长效、口服活性的 DPP4 抑制剂,Ki 为 0.6 nM。
-
Gemigliptin
一种新型强效、选择性、竞争性、口服活性 DPP4 抑制剂,具有治疗 2 型糖尿病的潜力。
021-51111890
购物车()
sales@molnova.cn

